Keratoconus is a progressive corneal disease where the cornea thins and bulges into a cone shape, distorting vision. It typically appears in adolescence or young adulthood, progresses over years, and can eventually cause significant vision loss if untreated. Modern keratoconus management is a multi-modality conversation, and the specific pathway depends on how advanced the disease is when you're diagnosed and what you're trying to accomplish.
Here's the honest comparison of the three main options: scleral lenses, corneal cross-linking, and corneal transplantation.
The keratoconus staging framework
Understanding your stage matters because different stages call for different treatments:
| Stage | Key features | Typical management |
|---|---|---|
| Suspect / subclinical | Subtle topographic irregularities, no visual symptoms | Monitoring, address risk factors (eye rubbing), glasses may still work |
| Mild | Detectable cone shape, mild vision distortion, glasses give incomplete correction | Consider cross-linking to halt progression; specialty contact lenses for vision |
| Moderate | Clear cone shape, significant astigmatism, glasses inadequate | Cross-linking if progressing; scleral lenses for vision; ICRS (Intacs) in some cases |
| Advanced | Severe corneal steepening, scarring, contact lens intolerance | Corneal transplant (DALK or PK) becomes primary option |
Scleral lenses: the vision-correction workhorse
What they are
Scleral lenses are large-diameter rigid gas-permeable contact lenses that vault over the entire cornea and rest on the sclera (the white of the eye) rather than touching the cornea itself. This creates a smooth optical surface over the irregular cone, essentially replacing the deformed cornea's optical function with the regular lens shape.
Where they shine
- Immediate vision improvement. A properly fit scleral lens often achieves the sharpest vision a keratoconus patient has had in years.
- All keratoconus stages. From mild to advanced, sclerals can provide functional vision when standard glasses and soft lenses have failed.
- Fully reversible. They can be removed and don't alter the underlying eye.
- Extended wear tolerance. Most patients can wear them 12-16 hours daily comfortably once fit properly.
Where they don't help
- Don't stop progression. Sclerals correct vision but don't address the underlying disease. Progression continues underneath them.
- Daily commitment. Insertion, removal, and cleaning routines every day, indefinitely.
- Cost over time. Lenses need replacement every 1-3 years; fitting adjustments periodically; consumable solutions ongoing.
- Fitting complexity. Getting a good fit requires specialty expertise. First fit rarely matches ideal fit; iteration over weeks is normal.
Corneal cross-linking: the progression-halting procedure
What it is
Corneal cross-linking (CXL) uses riboflavin (vitamin B2) drops applied to the cornea combined with UVA light exposure. The combination causes new chemical bonds to form between collagen fibers in the corneal stroma, mechanically strengthening the cornea and halting or slowing keratoconus progression.
Where it shines
- Halts progression in the majority of cases. Published success rates for stabilizing keratoconus progression run in the 80-95% range depending on protocol and patient selection.
- One-time procedure per eye. No ongoing maintenance after initial recovery.
- Preserves future options. A crosslinked cornea remains a candidate for scleral lenses, ICRS, or ultimately transplant if needed later.
Where it doesn't help
- Doesn't improve vision. CXL stops progression; it doesn't reverse the cornea's shape. Patients often still need scleral lenses or specialty correction after CXL for functional vision.
- Not appropriate for advanced disease. Very thin or heavily scarred corneas may not be candidates for standard CXL protocols. Modified protocols exist but with lower success rates.
- Not fully reversible. The chemical changes to the cornea are permanent. Rare complications include corneal haze, infection, and treatment failure.
- Recovery period. The epithelium is typically removed during the procedure, and recovery involves significant discomfort for the first several days.
Epi-on vs epi-off protocols
Standard "epi-off" CXL removes the epithelium before riboflavin application, allowing better penetration but longer painful recovery. Newer "epi-on" protocols preserve the epithelium, making recovery gentler but with somewhat lower efficacy. Most Colombian clinics offer both; discuss with the surgeon which is more appropriate for your case.
Corneal transplantation: the advanced-stage option
What it is
For patients with advanced keratoconus, corneal scarring, or contact lens intolerance, corneal transplantation replaces the affected corneal tissue with donor tissue. Two main techniques:
- Deep anterior lamellar keratoplasty (DALK): Replaces the front layers of the cornea while preserving the patient's endothelium. Preferred technique for keratoconus because it retains the patient's own endothelium (reducing rejection risk).
- Penetrating keratoplasty (PK): Full-thickness corneal transplant. Used when DALK isn't feasible or fails intraoperatively.
Where it fits
- Advanced keratoconus where other options have failed or aren't viable.
- Central corneal scarring from advanced disease, hydrops (corneal edema episodes), or prior interventions.
- Contact lens failure — patients who cannot achieve functional vision with any specialty lens.
The trade-offs
- Significant surgery with real risks including rejection, infection, and gradual endothelial cell loss over years.
- Long recovery. Visual recovery after DALK or PK takes 6-18 months, and residual refractive error (particularly astigmatism) often requires glasses, contacts, or LASIK enhancement after transplant.
- Lifelong monitoring for rejection episodes and immunosuppressive drop use for extended periods.
Modern sequential management
For a patient diagnosed with progressive keratoconus in 2026, the typical staged approach:
- Confirm progression with sequential imaging (Pentacam) over 6-12 months if not obvious at presentation.
- Cross-linking as soon as progression is confirmed and the cornea meets minimum thickness criteria. Best done when disease is mild-to-moderate.
- Vision correction with scleral lenses (or in mild cases, specialty soft lenses or glasses) as needed for functional vision. Continued long-term.
- Intracorneal ring segments (ICRS / Intacs) in select cases where combined with CXL to improve corneal regularity.
- Corneal transplant reserved for cases where the above have failed or aren't viable.
LASIK is contraindicated in keratoconus, and undiagnosed subclinical keratoconus that's operated with LASIK often develops into full-blown corneal ectasia (a keratoconus-like weakening) within months to years post-op. This is why modern LASIK screening protocols include epithelial mapping and detailed topography — to catch subclinical keratoconus before it's unmasked by surgery. If you've been told you're not a LASIK candidate specifically because of corneal irregularity, that's not necessarily a life sentence to glasses. Scleral lenses, cross-linking (if progressing), and ICL surgery for underlying refractive error are all options worth exploring.
Colombia's role in keratoconus management
Colombia's cornea specialty infrastructure — particularly in Bogotá and Medellín — includes cross-linking, scleral lens fitting, and corneal transplantation at international-quality standards. Cost is dramatically lower than US pricing across all modalities, and the coordinated care ecosystem allows for combined cross-linking-plus-lens-fitting-plus-follow-up in a single medical tourism trip when appropriate.
What to filter for when evaluating clinics:
- Cornea-specialty ophthalmologist, not general LASIK surgeon.
- Scleral lens fitting experience specifically (not just soft or standard RGP lens experience).
- Access to modern CXL platforms with both epi-on and epi-off protocols.
- Transplant capability if advanced disease is present.